Compare DataMetrex AI Ltd. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
CAD 10 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.17
-25.15%
1.10
Revenue and Profits:
Net Sales:
3 Million
(Quarterly Results - Dec 2025)
Net Profit:
-1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-47.06%
0%
-47.06%
6 Months
-70.0%
0%
-70.0%
1 Year
-90.0%
0%
-90.0%
2 Years
-98.12%
0%
-98.12%
3 Years
-99.0%
0%
-99.0%
4 Years
-99.32%
0%
-99.32%
5 Years
-98.57%
0%
-98.57%
DataMetrex AI Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-15.96%
EBIT Growth (5y)
3.92%
EBIT to Interest (avg)
-2.24
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.02
Sales to Capital Employed (avg)
2.60
Tax Ratio
13.88%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
15.03%
ROE (avg)
12.44%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.10
EV to EBIT
-2.51
EV to EBITDA
-3.23
EV to Capital Employed
1.12
EV to Sales
1.62
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-44.39%
ROE (Latest)
-25.15%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
2.90
2.30
26.09%
Operating Profit (PBDIT) excl Other Income
-0.90
0.10
-1,000.00%
Interest
0.10
0.00
Exceptional Items
-0.00
2.00
-100.00%
Consolidate Net Profit
-1.20
1.70
-170.59%
Operating Profit Margin (Excl OI)
-380.50%
-118.40%
-26.21%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is 26.09% vs 15.00% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is -170.59% vs 124.64% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
6.50
7.80
-16.67%
Operating Profit (PBDIT) excl Other Income
-1.20
-6.30
80.95%
Interest
0.30
0.10
200.00%
Exceptional Items
0.20
-9.40
102.13%
Consolidate Net Profit
-0.90
-19.10
95.29%
Operating Profit Margin (Excl OI)
-392.60%
-1,193.60%
80.10%
USD in Million.
Net Sales
Not Applicable: The company has declared_date for only one period
Consolidated Net Profit
Not Applicable: The company has declared_date for only one period
About DataMetrex AI Ltd. 
DataMetrex AI Ltd.
Pharmaceuticals & Biotechnology
Datametrex AI Ltd, formerly Everfront Ventures Corp, is a Canada-based company that is engaged in the technology sector. It is a Big Data and Artificial Intelligence(AI) company focused on the collection and sale of data from retail Point of Sale (POS) terminals and provides AI solutions for governments and corporations globally. Datametrex AI Ltd operates under the following divisions: Collection of Big Data and AI Solutions. The Company's solution extends the life of existing POS terminals and upgrades them to have the benefit of new cloud based terminals. Its product, DataTap, is a plug and play solution that allows merchants to collect and analyze data from multiple POS systems in one location or many locations.
Company Coordinates 
Company Details
2161 Yonge St Suite 210 , TORONTO ON : M4S 3A6
Registrar Details






